Sonoco Products (SON) PT Raised to $65 at BMO Capital Following News of Effective COVID Vaccine
Tweet Send to a Friend
BMO Capital analyst Mark Wilde raised the price target on Sonoco Products (NYSE: SON) to $65.00 (from $60.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
